A serial leader in biotech, Justin previously served as VP of Research at Indee Labs, where he led R&D and partnerships, securing contracts with top 10 pharma companies and winning two NIH Phase I SBIR grants. His work focused on applying new microfluidics technologies to expedite cell therapy manufacturing. Justin completed his PhD in Immunology at Stanford University in the lab of William Robinson, publishing the first report of a novel anti-cytokine autoantibody in IgG4-related disease, rheumatoid arthritis, and lupus, which revealed a new mechanism of pathogenesis and supported the potential repurposing of an FDA-approved therapeutic. With 17 publications, Justin’s expertise spans T and B cell mechanisms, biomarkers, and proteomics.
.png)
